Acadia Investor Says Officers Overhyped Drug's Prospects

By Emilie Ruscoe · December 19, 2023, 7:39 PM EST

An investor in biopharmaceutical company Acadia Pharmaceuticals Inc. has filed a derivative shareholder suit against the company's brass in San Diego federal court alleging the executives misrepresented its chances of receiving...

To view the full article, register now.